Venus Concept Inc Quick Ratio (VERO) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Venus Concept Inc   (NASDAQ: VERO)

Venus Concept Inc 's Quick Ratio

VERO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2025, Quick Ratio fell to 0.13 a new company low.

Within Medical Equipment & Supplies industry 182 other companies have achieved higher Quick Ratio than Venus Concept Inc in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 2868 to 3624.

Explain Quick Ratio?
How much Cash & cash equivalents VERO´s has?
What are VERO´s Current Liabilities?




VERO Quick Ratio (Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
Y / Y Current Liabilities Change 20.05 % -12.15 % 63.29 % 73.69 % 222.5 %
Y / Y Cash & cash equivalent Change -3.94 % -32.34 % -37.11 % -20.85 % -8.87 %
Quick Ratio MRQ 0.13 0.15 0.14 0.24 0.16
VERO's Total Ranking # 3624 # 2868 # 2905 # 2430 # 2844
Seq. Current Liabilities Change 31.53 % 13.5 % 21.89 % -34.03 % -3.75 %
Seq. Cash & cash equivalent Change 11.19 % 21.23 % -25.1 % -4.86 % -21.69 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 183
Healthcare Sector # 894
Overall Market # 3624


Quick Ratio Statistics
High Average Low
4.41 0.97 0.13
(Dec 31 2021)   (Sep 30 2025)




Financial Statements
Venus Concept Inc 's Current Liabilities $ 33 Millions Visit VERO's Balance sheet
Venus Concept Inc 's Cash & cash equivalent $ 4 Millions Visit VERO's Balance sheet
Source of VERO's Sales Visit VERO's Sales by Geography


Cumulative Venus Concept Inc 's Quick Ratio

VERO's Quick Ratio for the trailling 12 Months

VERO Quick Ratio

(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 22.87 % 52.01 % 93.13 % 66.42 % 35.09 %
Y / Y Cash & cash equivalent TTM Growth -24.36 % -25.09 % -17.83 % -14.35 % -28.68 %
Quick Ratio TTM 0.16 0.17 0.18 0.22 0.26
Total Ranking TTM # 4004 # 2791 # 2445 # 3075 # 3217
Seq. Current Liabilities TTM Growth 5.94 % -3.6 % 9.77 % 9.61 % 31.06 %
Seq. Cash & cash equivalent TTM Growth -1.12 % -10.48 % -9.64 % -5.43 % -2.07 %


On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2025 to $32.98 millions, cumulative Quick Ratio decreased to 0.16 below the Venus Concept Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 208 other companies have achieved higher Quick Ratio than Venus Concept Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 2791 to 4004.

Explain Quick Ratio?
How much Cash & cash equivalents VERO´s has?
What are VERO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 209
Healthcare Sector # 978
Within the Market # 4004


trailing twelve months Quick Ratio Statistics
High Average Low
1.86 0.61 0.1
(Mar 31 2019)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Smith and Nephew Plc  0.36 $ 573.000  Millions$ 1,595.000  Millions
Retractable Technologies Inc  0.36 $ 3.445  Millions$ 9.628  Millions
Intelligent Bio Solutions Inc   0.33 $ 1.660  Millions$ 5.062  Millions
Accuray Incorporated  0.33 $ 63.344  Millions$ 194.612  Millions
Adm Tronics Unlimited Inc   0.32 $ 0.321  Millions$ 1.018  Millions
Pavmed Inc   0.31 $ 3.103  Millions$ 9.902  Millions
Integer Holdings Corporation  0.29 $ 58.944  Millions$ 200.696  Millions
Nexgel Inc   0.28 $ 0.938  Millions$ 3.308  Millions
Ss Innovations International Inc  0.27 $ 5.682  Millions$ 21.188  Millions
Milestone Scientific Inc   0.27 $ 1.345  Millions$ 5.034  Millions
Escalon Medical Corp   0.26 $ 0.616  Millions$ 2.341  Millions
Bioventus Inc   0.26 $ 42.164  Millions$ 161.752  Millions
Dentsply Sirona Inc   0.26 $ 363.000  Millions$ 1,405.000  Millions
Stevanato Group S p a   0.24 $ 146.275  Millions$ 600.183  Millions
Interpace Biosciences Inc   0.24 $ 1.423  Millions$ 5.945  Millions
Boston Scientific Corporation  0.24 $ 1,275.000  Millions$ 5,328.000  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.24 $ 1.715  Millions$ 7.254  Millions
Ufp Technologies Inc   0.22 $ 18.226  Millions$ 82.226  Millions
Precision Optics Corporation Inc   0.18 $ 1.392  Millions$ 7.617  Millions
Zynex inc   0.18 $ 13.259  Millions$ 74.410  Millions
Bellevue Life Sciences Acquisition Corp  0.17 $ 2.177  Millions$ 12.523  Millions
Bausch and Lomb Corp  0.16 $ 310.000  Millions$ 1,896.000  Millions
National Vision Holdings Inc   0.13 $ 56.030  Millions$ 416.965  Millions
Venus Concept Inc   0.13 $ 4.312  Millions$ 32.975  Millions
Northview Acquisition Corp  0.13 $ 3.009  Millions$ 23.540  Millions
Nakamoto Inc   0.11 $ 24.185  Millions$ 214.460  Millions
The Cooper Companies Inc   0.11 $ 110.600  Millions$ 984.900  Millions
Dynatronics Corporation  0.09 $ 0.762  Millions$ 8.426  Millions
Agape Atp Corporation  0.09 $ 0.134  Millions$ 1.485  Millions
P3 Health Partners Inc   0.09 $ 37.714  Millions$ 423.954  Millions

Date modified: 2026-09-12T06:22:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.